Skip to main content
. 2023 Jan 4;13:1070660. doi: 10.3389/fimmu.2022.1070660

Figure 3.

Figure 3

Subgroup analysis of the pooled ORR. (A). Subgroup of CLL/SLL, the pooled ORR of CLL/SLL with TP53 mutation/17p−deletion and others. (B). Subgroup of iNHL, the pooled ORR of Follicular lymphoma (FL) and others. (C). Subgroup of aNHL, the pooled ORR of MCL and others. (D). Subgroup of PTCL, the pooled ORR of AITL and others.